𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Omnibus Two-Sample Test Procedures with Randomly Censored Data

✍ Scribed by J. A. Koziol; Y. S. Yuh


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
332 KB
Volume
24
Category
Article
ISSN
0323-3847

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A two-sample test with interval censored
✍ Wei Pan πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 1 views

Interval censored data arise naturally in large scale panel studies where subjects can only be followed periodically and the event of interest can only be recorded as having occurred between two examination times. In this paper we consider the problem of comparing two interval-censored samples. We p

A Test of Equality of Survival Distribut
✍ Dr. Terence J. O'Neill πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 454 KB πŸ‘ 2 views

A coninion testing problem for a life table or survival date is to test the equality of two survival distributions when the data is both grouped end censored. Several tests have been proposed in the literature which require various assumptions about the censoring distributions. It is shown that if t

A Nonparametric Test for Ordered Alterna
✍ Rhonda C. Magel πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 352 KB πŸ‘ 2 views

A nonparametric test is presented to test for ordered alternatives of the treatment effecta when the data follow a two-way layout. The observations are subject to arbitrary right censorehip. The test is similar to the one developed by H s r r a r a ~s ~m a m and NORTON (1987) for uncensored observat

A Monte Carlo procedure for two-stage te
✍ E. R. Martin; N. L. Kaplan πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 1 views

One strategy for mapping disease loci using marker-disease associations is to test for association with case-control samples and follow up a positive result with a family-based test. Using a family-based test in the second stage can help provide protection against false-positive results that can res